Xiao‐Feng Sun
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
Papers in
-
- MicroRNA in disease regulation 17
- Oncology 108
- Colorectal Cancer Treatments and Studies 34
- Cancer-related Molecular Pathways 20
- Colorectal Cancer Surgical Treatments 19
- Peptidase Inhibition and Analysis 17
- Co-authors
- Zong‐Guang ZhouWei ShenGunnar AdellGunnar ArbmanJohn CarstensenBo NordenskjöldShun‐Feng ChengAgneta Jansson
- Journals
- Oncology (8 papers)Oncotarget (8 papers)BMC Cancer (6 papers)PLoS ONE (6 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)
- Partner nations
- SwedenChinaUnited States
In The Last Decade
Xiao‐Feng Sun
233 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 167
- Cancer Research 1.8k
- Oncology 1.9k
- Pathology and Forensic Medicine 975
- Molecular Biology 3.2k
- Health Informatics 61
Countries citing papers authored by Xiao‐Feng Sun
This map shows the geographic impact of Xiao‐Feng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Sun more than expected).
Fields of papers citing papers by Xiao‐Feng Sun
This network shows the impact of papers produced by Xiao‐Feng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Sun. The network helps show where Xiao‐Feng Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao‐Feng Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 29 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2019 | 32 | |
| 14 | 2015 | 10 | |
| 15 | 2015 | 22 | |
| 16 | 2014 | 5 | |
| 17 | 2011 | 43 | |
| 18 | 2005 | 30 | |
| 19 | Anticancer effect of SN-38 on colon cancer cell lines with different metastatic potential | 2005 | 5 |
| 20 | 2004 | 42 |
About Xiao‐Feng Sun
Xiao‐Feng Sun is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Molecular Biology and Computational Mathematics, having authored 237 papers that have together received 6.3k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (47 papers), Colorectal Cancer Treatments and Studies (34 papers), Cancer-related Molecular Pathways (20 papers), Colorectal Cancer Surgical Treatments (19 papers), Colorectal and Anal Carcinomas (19 papers), Reproductive Biology and Fertility (17 papers), MicroRNA in disease regulation (17 papers) and Peptidase Inhibition and Analysis (17 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.9k citations), Pathology and Forensic Medicine (975 citations), Molecular Biology (3.2k citations) and Health Informatics (61 citations). Xiao‐Feng Sun has collaborated with scholars based in Sweden, China and United States. Frequent co-authors include Zong‐Guang Zhou, Wei Shen, Gunnar Adell, Gunnar Arbman, John Carstensen, Bo Nordenskjöld, Shun‐Feng Cheng, Agneta Jansson, Xifeng Zhang and Hong Zhang. Their work appears in journals such as Oncology, Oncotarget, BMC Cancer, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.